Statera Biopharma, Inc. Total Long-Term Debt
Statera Biopharma, Inc. had Total Long-Term Debt of $0 as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2022-11-14
- 2022-09-30: Long-term Debt $0.00.
- 2022-06-30: Long-term Debt $0.00.
- 2022-03-31: Long-term Debt $0.00.
- 2021-12-31: Long-term Debt $10.63M.
| Period end | Long-term Debt |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-10-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-10-21 |
| 2021-12-31 | $10.63M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $12.92M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-10-06 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 |
| 2015-06-30 | $1.14M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $1.32M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.50M 10-K · filed 2016-02-23 |
| 2014-09-30 | $3.48M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.63M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $6.73M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $7.12M 10-K · filed 2015-02-27 |
| 2013-09-30 | $7.33M 10-Q · filed 2013-11-08 |